Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for paratesticular adenocarcinoma.
5 publications have been identified in PubMed for paratesticular adenocarcinoma. Research spans Case Report / Case Series (60%), Review / Meta-Analysis (20%), and Clinical Trial Publication (20%).
Matoso A (2026). [PMID: 41368924](https://pubmed.ncbi.nlm.nih.gov/41368924/). *Am J Surg Pathol*. [Case Report / Case Series]
Vega M (2025). [PMID: 39890299](https://pubmed.ncbi.nlm.nih.gov/39890299/). *Surg Pathol Clin*. [Review / Meta-Analysis]
Shahabi A (2025). [PMID: 40511957](https://pubmed.ncbi.nlm.nih.gov/40511957/). *Am J Surg Pathol*. [Clinical Trial Publication]
Maniam G (2024). [PMID: 39008503](https://pubmed.ncbi.nlm.nih.gov/39008503/). *Am J Dermatopathol*. [Case Report / Case Series]
Kilic I (2024). [PMID: 38990735](https://pubmed.ncbi.nlm.nih.gov/38990735/). *Am J Surg Pathol*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 10:30 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center